Abbott Laboratories

BVL:ABT

미국 / 헬스케어 / 의료 장비 및 용품

개요

뉴스

5년 과거 금융 데이터

주가

128.20 USD


Key Metrics	Latest
Total Revenue	41.95 B
Adjusted EBITDA	10.714 B
EBITDA Margin	25.5%
Net Profit Margin	32.2%
Total Assets	81.414 B
Total Debt	15.275 B

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months	Dec-23	Dec-24

Revenue	34,608.00	43,075.00	43,653.00	40,109.00	41,950.00	41,950.00	40,109.00	41,950.00
% Growth		0.24	0.01	(0.08)	0.05			0.05

Adjusted EBITDA	8,789.00	12,742.00	12,380.00	10,463.00	10,714.00	10,714.00	10,463.00	10,714.00
% Margin	0.25	0.30	0.28	0.26	0.26	0.26	0.26	0.26

Adjusted EBIT	5,462.00	9,204.00	9,113.00	7,220.00	7,496.00	7,496.00	7,220.00	7,496.00
% Margin	0.16	0.21	0.21	0.18	0.18	0.18	0.18	0.18

Adjusted Net Income	4,506.10	7,447.66	7,188.30	5,901.34	13,497.46	13,497.46	5,901.34	13,497.46
% Margin	0.13	0.17	0.16	0.15	0.32	0.32	0.15	0.32

Adjusted Basic EPS	2.54	4.20	4.10	3.39	7.76	7.76	3.39	7.76

지원하는 계산법

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Original
USD	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	34,608	43,075	43,653	40,109	41,950	41,950	40,109	41,950
% Growth	NA	24.5%	1.3%	-8.1%	4.6%			4.6%

Cost of Revenue	(15,003)	(18,080)	(19,083)	(17,919)	(18,644)	(18,644)	(17,919)	(18,644)
Gross Profit	19,605	24,995	24,570	22,190	23,306	23,306	22,190	23,306
% Revenue	56.6%	58.0%	56.3%	55.3%	55.6%	55.6%	55.3%	55.6%

Research and Development	(2,420)	(2,742)	(2,888)	(2,741)	(2,844)	(2,844)	(2,741)	(2,844)
Selling and Marketing	0	0	0	0	0	0	0	0
General and Admin	(9,591)	(11,006)	(10,703)	(10,385)	(11,109)	(11,109)	(10,385)	(11,109)
Other Inc / (Exp)	(2,126)	(2,546)	(2,298)	(2,148)	(2,125)	(2,125)	(2,148)	(2,125)
Total Operating Exp	(14,137)	(16,294)	(15,889)	(15,274)	(16,078)	(16,078)	(15,274)	(16,078)

Operating Income	5,468	8,701	8,681	6,916	7,228	7,228	6,916	7,228
% Revenue	15.8%	20.2%	19.9%	17.2%	17.2%	17.2%	17.2%	17.2%

Interest Expense	(500)	(490)	(375)	(252)	(215)	(215)	(252)	(215)
Pre-tax Income	4,968	8,211	8,306	6,664	7,013	7,013	6,664	7,013
Earnings of Discontinued Ops.	24	0	0	0	0	0	0	0
Provision for Taxes	(497)	(1,140)	(1,373)	(941)	6,389	6,389	(941)	6,389
Net Income to Company	4,495	7,071	6,933	5,723	13,402	13,402	5,723	13,402
% Margin	13.0%	16.4%	15.9%	14.3%	31.9%	31.9%	14.3%	31.9%

Minority Interest in Earnings	0	0	0	0	0	0	0	0
Net Income to Stockholders	4,495	7,071	6,933	5,723	13,402	13,402	5,723	13,402

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	(46)	(29)	(28)	(22)	(51)	(51)	(22)	(51)

Net Income to Common	4,449	7,042	6,905	5,701	13,351	13,351	5,701	13,351
% Margin	12.9%	16.3%	15.8%	14.2%	31.8%	31.8%	14.2%	31.8%

As Reported
Basic EPS (Continuing Ops)	2.51	3.97	3.94	3.28	7.67	7.67	3.28	7.67
Diluted EPS (Continuing Ops)	2.49	3.94	3.91	3.26	7.64	7.64	3.26	7.64

WA Basic Shares Out.	1,773.00	1,775.00	1,753.00	1,740.00	1,740.00	1,740.00	1,740.00	1,740.00
WA Diluted Shares Out.	1,786.00	1,789.00	1,764.00	1,749.00	1,748.00	1,748.00	1,749.00	1,748.00

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	4,968	8,211	8,306	6,664	7,013	7,013	6,664	7,013
Addback: Net Interest Expense	500	490	375	252	215	215	252	215
Addback: Other Non Operating Expenses, Total	(21)	(6)	87	63	139	139	63	139
Addback: Depreciation & Amortization	3,327	3,538	3,267	3,243	3,218	3,218	3,243	3,218
Addback: Restructuring Charges	0	509	234	144	129	129	144	129
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	115	0	0	39	0	0	39	0
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	0	0	0
Addback: Asset Writedown	0	0	111	100	0	0	100	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	(100)	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	0	0	(42)	0	0	(42)	0
Adjusted EBITDA	8,789	12,742	12,380	10,463	10,714	10,714	10,463	10,714
% Margin	25.4%	29.6%	28.4%	26.1%	25.5%	25.5%	26.1%	25.5%

Adjusted EBIT	5,462	9,204	9,113	7,220	7,496	7,496	7,220	7,496
% Margin	15.8%	21.4%	20.9%	18.0%	17.9%	17.9%	18.0%	17.9%

Adjusted Net Income Reconciliation
Net Income to Company	4,495	7,071	6,933	5,723	13,402	13,402	5,723	13,402
Addback: Unusual Items	15	509	345	241	129	129	241	129
Less: Tax Benefit of Unusual Items (26%)	(4)	(132)	(90)	(63)	(34)	(34)	(63)	(34)
Adjusted Net Income	4,506	7,448	7,188	5,901	13,497	13,497	5,901	13,497
% Margin	13.0%	17.3%	16.5%	14.7%	32.2%	32.2%	14.7%	32.2%

로딩 에러

Abbott Laboratories

BVL:ABT

미국 / 헬스케어 / 의료 장비 및 용품

5년 과거 금융 데이터